Clinical Trial Update: Nepal Undifferentiated Febrile Illness Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of undifferentiated febrile illness conducted in Nepal has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Undifferentiated Febrile Illness

Snippet

Sponsor: Oxford University Clinical Research Unit, Vietnam | Conditions: Undifferentiated Febrile Illness | Phase 3 | Status: COMPLETED